INTEGRATING BOTULINUM THERAPY WITH MULTIMODAL STIMULATION AND INNOVATIVE APPROACHES IN HAND SPASTICITY: A LITERATURE REVIEW
##plugins.themes.academic_pro.article.main##
Abstract
Post-stroke spasticity limits voluntary hand movement, leading to pain and
contractures. According to global research, approximately 30 percent of patients who
have had a stroke develop spasticity in the upper limbs. Botulinum toxin type A
(BTA) is considered the primary choice for reducing spasticity as a focal myorelaxant.
In recent years, combining BTA with early neurorehabilitation, multimodal
stimulation, and new local preparations is developing as an individualized and
innovative approach.